Genotype and phenotype in Parkinson's disease: Lessons in heterogeneity from deep brain stimulation
Open Access
- 1 July 2013
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 28 (10) , 1370-1375
Abstract
Variation in the genetic risk(s) of developing Parkinson's disease (PD) undoubtedly contributes to the subsequent phenotypic heterogeneity. Although patients with PD who undergo deep brain stimulation (DBS) are a skewed population, they represent a valuable resource for exploring the relationships between heterogeneous phenotypes and PD genetics. In this series, 94 patients who underwent DBS were screened for mutations in the most common genes associated with PD. The consequent genetic subgroups of patients were compared with respect to phenotype, levodopa (l‐dopa), and DBS responsiveness. An unprecedented number (29%) of patients tested positive for at least 1 of the currently known PD genes. Patients with Parkin mutations presented at the youngest age but had many years of disease before needing DBS, whereas glucocerebrosidase (GBA) mutation carriers reached the threshold of needing DBS earlier, and developed earlier cognitive impairment after DBS. DBS cohorts include large numbers of gene positive PD patients and can be clinically instructive in the exploration of genotype‐phenotype relationships.Keywords
This publication has 24 references indexed in Scilit:
- Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohortBrain, 2013
- Cognitive performance of GBA mutation carriers with early-onset PDNeurology, 2012
- Mitochondrial diseasesThe Lancet, 2012
- Long-term follow-up of subthalamic nucleus stimulation in glucocerebrosidase-associated Parkinson’s diseaseJournal of Neurology, 2012
- Parkinson's disease, insulin resistance and novel agents of neuroprotectionBrain, 2012
- Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2Annals of Neurology, 2011
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron DeathNeuron, 2011
- A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's DiseasePLOS Genetics, 2011
- Phenotype analysis in patients with early onset Parkinson’s disease with and without parkin mutationsJournal of Neurology, 2011
- MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safetyJournal of Neurology, Neurosurgery & Psychiatry, 2010